News Medical on MSN13d
Over-dilation of microvasculature may contribute to chronic limb-threatening ischemiaPersistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland show ...
Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase ...
UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for ...
Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland ...
Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...
Miami's Community Newspapers on MSN12d
Patty Vila Joins the Amavita Foundation Board, Bringing Expertise to Amplify Heart and Vascular Health InitiativesThe Amavita Foundation, a leading organization dedicated to advancing cardiovascular health and supporting patients facing ...
The Amavita Foundation, a leading organization dedicated to advancing cardiovascular health and supporting patients facing chronic limb-threatening ischemia (CLTI), is pleased to announce the ...
This end-stage of the disease is called chronic limb-threatening ischaemia. The survival of people with this stage of the disease is worse than many cancers - less than 50 per cent will be alive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback